Advertisement

Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: a case report and review of the literature

Abstract

Prostate cancer is the first cause of skull metastases in men, accounting for 12-18% of all cases. This condition is generally a late event in the course of the disease, involving patients with disseminated lesions. Quite rarely is skull involvement the first and single site of distant recurrence. We report the case of a patient who developed a single skull lesion 15 years after primary treatment of prostate cancer, in the presence of undetectable PSA levels. Pathological assessment performed after resection of the lesion revealed a metastasis from prostate carcinoma. Basing on this experience the appearance of craniofacial pain or a nerve deficit in patients with a history of prostate cancer should alert the clinician to exclude distant recurrence of disease, even in the presence of undetectable PSA levels and even if many years have elapsed since the treatment of the primary tumor. Knowledge of these manifestations will reduce any diagnostic delay and lead to the effective delivery of appropriate treatment.

Tumori 2013; 99(5): e220 - e224

Article Type: CASE REPORT

DOI:10.1700/1377.15319

Authors

Marco Messina, Francesco Ricci, Bruno Spina, Francesco Boccardo

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Messina, Marco [PubMed] [Google Scholar]
    Department of Internal Medicine, School of Medicine, University of Genoa, Genoa (current address: Department of Medical Oncology, San Raffaele G Giglio Foundation Institute, Cefalù), IRCCS San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy
  • Ricci, Francesco [PubMed] [Google Scholar]
    Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, IRCCS San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy
  • Spina, Bruno [PubMed] [Google Scholar]
    Department of Histopathology and Cytology, IRCCS San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy
  • Boccardo, Francesco [PubMed] [Google Scholar]
    Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, IRCCS San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.